Trademark: 86983080
Status Date
Tuesday, November 7, 2017
Registration Number
5330559
Registration Date
Tuesday, November 7, 2017
Filing Date
Thursday, June 11, 2015
Published for Opposition
Tuesday, January 19, 2016
5 Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, namely, cancer and Mendelian disorders; test kits consisting of medical diagnostic reagents and assays for testing in the field of the prevention and treatment of disorders and diseases; none of the aforementioned involve the use or study of semaphorins
35 Business consulting and business information services regarding precision health diagnosis and personalized treatment; business consulting and business information services regarding the analysis and packaging of health data; providing business information, namely, commercial corporate and statistical information provided on-line from a computer database or the Internet; statistical analysis and reporting services for business purposes; business consulting and business information services regarding the identification of drug targets; business consulting and business information services regarding bioinformatic analysis; population health management
1 Kits containing chemical and biochemical assays and reagents for scientific research use; nucleic acid and protein isolation kits comprised primarily of assays and reagents for use in epigenetic research and analysis; none of the aforementioned involve the use or study of semaphorins
44 Diagnostic services in the field of medicine; medical testing for diagnosis of diseases and treatment purposes; bioinformatics analysis for medical diagnostic and personalized treatment purposes; biochemical testing for ancestry analysis and personalized diagnostics and treatments; nucleic acid analysis and screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; health care services, namely, leveraging health monitoring and data science to provide optimal health and disease prevention to patients; creating personalized preventative health-care programs and disease management programs; providing an online resource center featuring personalized health information based on health information and diagnostics; medical testing, namely, identifying drug targets for diagnostic or treatment purposes; none of the aforementioned involve the use or study of semaphorins
42 Medical and scientific research in the field of biologic testing and interpretation, diagnosis, treatment, and health maintenance; bioinformatics interpretation of health data; medical and scientific research in the field of ancestry analysis for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; providing information in the field of disease classification for use in connection with diagnostic testing; development of scientific research and technology for purposes of disease diagnosis, preventative health care, health monitoring, and personalized treatment; providing a website featuring non-downloadable software for patient access to health care services and health information; providing a website featuring non-downloadable software for patient access to diagnosis, treatment, and health maintenance information; providing a website featuring non-downloadable software for accessing, viewing, interacting with and downloading personal health records, diagnoses, treatment plans, and health monitoring information; scientific and medical research, namely, identifying drug targets; scientific research relating to population health management; none of the aforementioned involve the use or study of semaphorins
In the statement, Column 1, line 1, "New York" should be deleted, and Delaware should be inserted.
SEMA FOUR
Nov 8, 2023
Assignment Of Ownership Not Updated Automatically
Nov 7, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 10, 2022
Teas Change Of Correspondence Received
May 10, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 10, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 4, 2021
Automatic Update Of Assignment Of Ownership
May 7, 2018
Correction Under Section 7 ¿ Processed
May 7, 2018
Teas Response To Office Action-Post Reg Received
Dec 27, 2017
Post Registration Action Mailed - Sec. 7
Dec 27, 2017
Case Assigned To Post Registration Paralegal
Nov 27, 2017
Fax Received
Nov 20, 2017
Teas Section 7 Request Received
Nov 7, 2017
Registered-Principal Register
Sep 30, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 29, 2017
Allowed Principal Register - Sou Accepted
Sep 13, 2017
Statement Of Use Processing Complete
Sep 11, 2017
Use Amendment Filed
Sep 13, 2017
Divisional Processing Complete
Sep 11, 2017
Divisional Request Received
Sep 11, 2017
Teas Request To Divide Received
Sep 11, 2017
Teas Statement Of Use Received
Aug 30, 2017
Automatic Update Of Assignment Of Ownership
Mar 17, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2017
Sou Extension 2 Granted
Mar 15, 2017
Sou Extension 2 Filed
Mar 15, 2017
Sou Teas Extension Received
Nov 30, 2016
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2016
Sou Extension 1 Granted
Sep 15, 2016
Sou Extension 1 Filed
Nov 28, 2016
Case Assigned To Intent To Use Paralegal
Oct 20, 2016
Teas Change Of Correspondence Received
Oct 20, 2016
Notice Of Revival - E-Mailed
Oct 20, 2016
Sou Extension Received With Teas Petition
Oct 20, 2016
Petition To Revive-Granted
Oct 20, 2016
Teas Petition To Revive Received
Oct 17, 2016
Abandonment Notice Mailed - No Use Statement Filed
Oct 17, 2016
Abandonment - No Use Statement Filed
Mar 15, 2016
Noa E-Mailed - Sou Required From Applicant
Jan 19, 2016
Official Gazette Publication Confirmation E-Mailed
Jan 19, 2016
Published For Opposition
Dec 30, 2015
Notification Of Notice Of Publication E-Mailed
Dec 15, 2015
Approved For Pub - Principal Register
Dec 10, 2015
Teas/Email Correspondence Entered
Dec 8, 2015
Correspondence Received In Law Office
Dec 8, 2015
Teas Response To Office Action Received
Jul 16, 2015
Notification Of Non-Final Action E-Mailed
Jul 16, 2015
Non-Final Action E-Mailed
Jul 16, 2015
Non-Final Action Written
Jul 11, 2015
Assigned To Examiner
Jun 16, 2015
Notice Of Pseudo Mark E-Mailed
Jun 15, 2015
New Application Office Supplied Data Entered
Jun 15, 2015
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
